Literature DB >> 24698351

Resistant starch improves insulin resistance and reduces adipose tissue weight and CD11c expression in rat OLETF adipose tissue.

Tomomi Harazaki1, Seiya Inoue1, Chihiro Imai1, Kazuki Mochizuki2, Toshinao Goda3.   

Abstract

OBJECTIVE: CD11s/CD18 dimers induce monocyte/macrophage infiltration into many tissues, including adipose tissues. In particular, it was reported that β2-integrin CD11c-positive macrophages in adipose tissues are closely associated with the development of insulin resistance. The aim of this study was to determine whether intake of resistant starch (RS) reduces macrophage accumulation in adipose tissues and inhibits the development of insulin resistance at an early stage in Otsuka Long-Evans Tokushima Fatty (OLETF) rats.
METHODS: Twenty-two-wk-old male OLETF rats were fed a control diet (55% α-corn starch) or an RS diet (55% RS) for 5 wk. An oral glucose tolerance test was performed after 4 wk of feeding; tissues (mesenteric and epididymal adipose tissues, and liver) and tail vein blood were collected after 5 wk of feeding the test diets.
RESULTS: Feeding the RS diet to OLETF rats for 5 wk improved insulin resistance, reduced the mesenteric adipose tissue weight, and enhanced the number of small adipocytes. CD68 expression, a macrophage infiltration marker, was not changed by the RS diet, whereas the gene expression levels of integrins such as CD11c, CD11d, and CD18, but not CD11a, and CD11b, were significantly reduced. CD11c protein expression was reduced by the RS diet.
CONCLUSION: These findings suggest that part of the mechanism for the improved insulin resistance by the RS diet involves a reduction of CD11c expression in adipose tissues.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adipose tissue; CD11c-positive macrophage; OLETF rat; Resistant starch; β2-integrin

Mesh:

Substances:

Year:  2013        PMID: 24698351     DOI: 10.1016/j.nut.2013.10.020

Source DB:  PubMed          Journal:  Nutrition        ISSN: 0899-9007            Impact factor:   4.008


  7 in total

Review 1.  Resistant starches for the management of metabolic diseases.

Authors:  Laure B Bindels; Jens Walter; Amanda E Ramer-Tait
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2015-11       Impact factor: 4.294

2.  A novel gene network analysis in liver tissues of diabetic rats in response to resistant starch treatment.

Authors:  Zhiwei Wang; Yinghui Zhang; Runge Shi; Zhongkai Zhou; Fang Wang; Padraig Strappe
Journal:  Springerplus       Date:  2015-03-05

3.  Resistant starch can improve insulin sensitivity independently of the gut microbiota.

Authors:  Laure B Bindels; Rafael R Segura Munoz; João Carlos Gomes-Neto; Valentin Mutemberezi; Inés Martínez; Nuria Salazar; Elizabeth A Cody; Maria I Quintero-Villegas; Hatem Kittana; Clara G de Los Reyes-Gavilán; Robert J Schmaltz; Giulio G Muccioli; Jens Walter; Amanda E Ramer-Tait
Journal:  Microbiome       Date:  2017-02-07       Impact factor: 14.650

4.  Metabolic phenotypes and the gut microbiota in response to dietary resistant starch type 2 in normal-weight subjects: a randomized crossover trial.

Authors:  Lei Zhang; Yang Ouyang; Huating Li; Li Shen; Yueqiong Ni; Qichen Fang; Guangyu Wu; Lingling Qian; Yunfeng Xiao; Jing Zhang; Peiyuan Yin; Gianni Panagiotou; Guowang Xu; Jianping Ye; Weiping Jia
Journal:  Sci Rep       Date:  2019-03-20       Impact factor: 4.379

5.  Metabolic dysfunction in pregnancy: Fingerprinting the maternal metabolome using proton nuclear magnetic resonance spectroscopy.

Authors:  Hannah D Scott; Marrissa Buchan; Caylin Chadwick; Catherine J Field; Nicole Letourneau; Tony Montina; Brenda M Y Leung; Gerlinde A S Metz
Journal:  Endocrinol Diabetes Metab       Date:  2020-11-18

Review 6.  The Potential of Sweetpotato as a Functional Food in Sub-Saharan Africa and Its Implications for Health: A Review.

Authors:  Flora C Amagloh; Benard Yada; Gaston A Tumuhimbise; Francis K Amagloh; Archileo N Kaaya
Journal:  Molecules       Date:  2021-05-17       Impact factor: 4.411

7.  Identification of cysteinylated transthyretin, a predictive biomarker of treatment response to partially hydrolyzed guar gum in type 2 diabetes rats, by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.

Authors:  Yuji Naito; Hiroshi Ichikawa; Satomi Akagiri; Kazuhiko Uchiyama; Tomohisa Takagi; Osamu Handa; Zenta Yasukawa; Makoto Tokunaga; Noriyuki Ishihara; Tsutomu Okubo; Jun Mukai; Makoto Ohki; Kagehiro Uchida; Toshikazu Yoshikawa
Journal:  J Clin Biochem Nutr       Date:  2015-12-08       Impact factor: 3.114

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.